Cancer immunotherapy has been firmly established as a new milestone for cancer therapy with the development of multiple immune cells as therapeutic tools.
The application of natural killer cell immunotherapy for the treatment of cancer.
Engineering natural killer cells for cancer immunotherapy the past several years have seen tremendous advances in the engineering of immune effector cells as therapy for cancer.
Despite reports of clinical efficacy a number of factors limit the application of nk cell immunotherapy for the treatment of cancer such as the failure of infused nk cells to expand and persist in vivo.
Despite reports of clinical efficacy a number of factors limit the application of nk cell immunotherapy for the treatment of cancer such as the failure of infused nk cells to expand and persist.